Frank Pallone actually said...
I wanted to ask Mr. Francer some questions. The committee has heard concerns from FDA regarding the public health concerns associated with illicit, unapproved, or counterfeit drugs entering our supply chain.
Context
Raising concerns about the risks of counterfeit drugs in the supply chain.
03/20/2018